Selected article for: "analysis compare and overall risk"
Author: Mai, Vicky; Tan, Boun Kim; Mainbourg, Sabine; Potus, François; Cucherat, Michel; Lega, Jean-Christophe; Provencher, Steeve
Title: Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis
  • Cord-id: f8cjhzz4
  • Document date: 2021_6_2
    • ID: f8cjhzz4
    Snippet: BACKGROUND: Many studies confirmed an association between COVID-19 and venous thromboembolism (VTE). Whether the risk of VTE significantly differed between COVID-19 cohorts and non-COVID-19 cohorts with similar disease severity remains unknown. OBJECTIVES: The aim of this systematic review with meta-analysis was to compare the rate of VTE between COVID-19 and non-COVID-19 cohorts with similar disease severity. METHODS: A systematic literature search (MEDLINE, Embase and Google Scholar) was condu
    Document: BACKGROUND: Many studies confirmed an association between COVID-19 and venous thromboembolism (VTE). Whether the risk of VTE significantly differed between COVID-19 cohorts and non-COVID-19 cohorts with similar disease severity remains unknown. OBJECTIVES: The aim of this systematic review with meta-analysis was to compare the rate of VTE between COVID-19 and non-COVID-19 cohorts with similar disease severity. METHODS: A systematic literature search (MEDLINE, Embase and Google Scholar) was conducted from January 1, 2020 to March 31, 2021 to identify studies reporting VTE in COVID-19. Relative risks (RR) were estimated for the effect measure with 95% confidence intervals. RESULTS: Seven studies (41,768 patients) evaluated VTE in COVID-19 cohorts compared to non-COVID-19 cohorts. The overall risk of VTE (RR 1.18; 95%CI 0.79–1.77; p = 0.42; I(2) = 54%), pulmonary embolism (RR 1.25; 95%CI 0.77–2.03; p = 0.36; I(2) = 52%) and deep venous thrombosis (RR 0.92; 95%CI 0.52–1.65; p = 0.78; I(2) = 0%) did not significantly differ between COVID-19 and non-COVID-19 cohorts. However, subgroup analyses suggested an increased risk of VTE amongst CODID-19 versus non COVID-19 cohorts when only patients hospitalized within the intensive care unit (ICU) were considered (RR 3.10; 95%CI 1.54–6.23), which was not observed in cohorts of predominantly non-ICU patients (RR 0.95; 95%CI 0.81–1.11) (P(interaction) = 0.001). CONCLUSION: There was no signal for a difference in VTE in COVID-19 cohorts compared to non-COVID-19 cohorts, except for the subgroup of patients hospitalized in the ICU. These results should be viewed as exploratory and further studies are needed to confirm these results.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and admission rate: 1
    • absence presence and local experience: 1
    • absence presence and long period: 1, 2, 3, 4, 5
    • absence presence and lung coagulopathy: 1
    • absence presence and lung perfusion: 1
    • abstract title and acute ards respiratory distress syndrome: 1
    • abstract title and low consider: 1
    • abstract title and low strength: 1
    • acute ards respiratory distress syndrome and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute ards respiratory distress syndrome and local experience: 1
    • acute ards respiratory distress syndrome and long period: 1, 2
    • acute ards respiratory distress syndrome and low strength: 1, 2
    • acute ards respiratory distress syndrome and lung coagulopathy: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung mechanic: 1
    • acute ards respiratory distress syndrome and lung perfusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • admission rate and long period: 1
    • local experience and long period: 1